- 15 Μαρ 2020, 11:16
#633207
The Tübingen-based company CureVac is researching a corona vaccine under high pressure. According to WELT AM SONNTAG information, the US government wants to secure the rights to it exclusively. The German government is trying to prevent this.
Between the United States and Germany, the Corona crisis is reported to lead to an indirect but tangible economic policy debate. The reason: Us President Donald Trump tries to lure German scientists working on a potential corona vaccine to America with high financial donations or to secure the drug exclusively for his country. WELT AM SONNTAG experienced this in government circles.
The US president allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. "But only for the USA," says the federal government.
According to information from WELT AM SONNTAG, the dispute between the two states is about the company CureVac, which is based in Tübingen and works together with the federally owned Paul Ehrlich Institute for Vaccines and Biomedical Medicines on the production of a vaccine against the virus. Government officials are now negotiating with CureVac.
"The Federal Government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe," confirmed a spokesman for the Ministry of Health WELT AM SONNTAG. "In this regard, the government is in intensive exchange with the company CureVac." In Berlin, one hears, try to keep the company with financial offers. The company itself refused to answer questions.
https://www.welt.de/wirtschaft/article2 ... Firma.html
